Skip to main content
Advertisement
  • Loading metrics

Dual contributions of Xrp1 to genome integrity through the DNA damage response and cell competition

  • Chaitali Khan,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing

    Present address: Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

    Affiliation Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America

    ⨯
  • Nasser M. Rusan,

    Roles Funding acquisition, Resources, Supervision

    Affiliation Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    ⨯
  • Nicholas E. Baker

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

    nebaker@uci.edu

    Present address: Department of Microbiology and Molecular Genetics, and Department of Developmental and Cell Biology, University of California, Irvine, California, United States of America

    Affiliation Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America

    ⨯

Abstract

Model organisms may help understand how p53 suppresses tumorigenesis in mammals. In Drosophila, the primary transcriptional target of p53 is the gene encoding the bZip AT-hook protein Xrp1, which is another transcription factor. We report that Xrp1 mediates multiple functions of p53 in the DNA damage response (DDR), contributing to p53-dependent gene transcription and DNA damage-induced apoptosis. In addition to this role as a p53 effector, a p53-independent role for Xrp1 in cell competition has been described. Cell competition can remove cells whose genome has been altered by DNA damage and repair. During cell competition, Xrp1 is induced by RpS12, which acts as a sensor of defective ribosome biogenesis. In irradiated discs, p53-independent RpS12-dependent Xrp1 function began as the DDR came to an end, and was even more prominent if p53 function was reduced. Such p53 inhibition resulted in persistence of DNA damage after irradiation, revealed by γH2Av accumulation. Thus, Xrp1 limited the accumulation of abnormal cells resulting from genotoxicity through both the acute, p53-dependent DDR, and also a later mechanism consistent with cell competition removing cells where DNA repair did not restore the normal genome. Both these processes might contribute to the tumor suppressor function of p53 in mammals.

Author summary

Accurately maintaining somatic cell genomes helps to prevent cancer. This is accomplished in part by a DNA Damage Response that activates repair genes when DNA damage is detected, and can also kill cells where damage is too extensive. A second mechanism is the selective loss of aneuploid cells even after DNA repair has been completed. The Drosophila transcription factor Xrp1 is expressed in both the DNA Damage Response and in many aneuploid cells. We find that Xrp1 mediates most of the gene expression changes caused by DNA damage, and that both DNA repair and the death of badly damaged cells are less effective without Xrp1. We also extend previous studies of aneuploid cells by showing that Xrp1 function continues to contribute to eliminating cells after DNA damage has been resolved, where Xrp1 is induced by RpS12, a protein that signals decreased ribosomal protein gene dose and initiates cell competition. The synergy between these two processes may offer insight into origins of human cancer. P53, one of the most important human tumor suppressor genes, has both these same functions of marshaling the transcriptional DNA Damage Response as well as stimulating cell competition to remove damaged cells.

Introduction

Xrp1 is a Drosophila transcription factor that was discovered as a p53 target and found to contribute to genome integrity, consistent with a role in the DNA damage response [1,2]. More recently, Xrp1 has been found to control multiple types of cell competition [3–11]. Because cell competition can preserve genome integrity, through the removal of aneuploid cells [12,13], we evaluated the role of Xrp1 in DNA repair and its relationship to cell competition in more detail. We confirmed that Xrp1 executes part of the DNA damage response downstream of p53, and a later p53-independent role consistent with cell competition, and present evidence that the DNA damage response and cell competition synergize to maintain genome integrity.

Genome integrity is important in somatic cells as well as in the germline. Defects in DNA repair are associated with elevated cancer incidences, and defects in mitotic fidelity occur in aging [14–17]. Errors in DNA repair can result in aneuploidy, as found in most cancer cells, and both mouse models and human genetic diseases that predispose to aneuploidy are cancer prone [18–20]. The most important human tumor suppressor, p53, is well known as a transcriptional master regulator of the DNA damage response (DDR) that regulates both DNA repair genes and the apoptotic elimination of cells with damaged DNA [21,22]. P53 also has other functions, and it has been questioned whether the DDR is, in fact, responsible for its tumor suppressor function [23,24]. One other function is cell competition, in which damaged cells can be removed only when they are less fit than their neighbors [25–32]. Cell competition removes cells with damage that would be tolerated by cell-autonomous mechanisms [33]. In Drosophila, cell competition eliminates cells independently of p53 [34], but in mammals, p53 activities too low to cause apoptosis by cell-autonomous mechanisms can trigger competitive cell removal when compared with less affected surrounding cells [35–40].

In Drosophila, the Xrp1 gene is a potential link between the DNA damage response and cell competition. Xrp1 was first described as a transcriptional target of p53, encodes a Drosophila bZip domain protein, and is transcriptionally induced by p53 when Drosophila embryos are irradiated [1,2]. Flies lacking wild-type Xrp1 exhibit increased sensitivity to irradiation. Specifically, they show increased loss of heterozygosity in an assay that quantifies patches of cells expressing the recessive multiple wing hair (mwh) phenotype in otherwise mwh+/- individuals, indicative of somatic loss of the mwh+ allele [1]. This loss of heterozygosity following irradiation is consistent with a role for Xrp1 in the DDR, downstream of p53.

Xrp1 was later identified as a central regulator of the cell competition of ‘Minute’ (Ribosome protein gene heterozygous mutant) cells in imaginal discs [3,8,9]. Ribosomal protein (Rp) mutant cells provided the first example of cell competition described in Drosophila [41]. Most Rp genes are essential, so Rp mutations are generally homozygously lethal, whereas Rp+/- heterozygotes survive with a developmental delay, thin bristles, and some other traits [42,43]. In contrast to whole Rp+/- animals, individual Rp+/- cells or clones are eliminated from many tissues when wild-type cells are also present, suffering an enhanced rate of apoptosis [41,44–47]. The Xrp1 protein is expressed at only low levels in wild-type imaginal discs, but Xrp1 protein is robustly induced in Rp+/- cells, where it is required for transcriptional changes in Rp+/- wing discs and for many aspects of the Rp+/- phenotype, including both developmental delay and cell competition [3,8,48]. Xrp1 binds to DNA as a heterodimer with another protein, Irbp18. Unlike Xrp1, Irbp18 is abundantly expressed in wild-type imaginal disc cells [49–51]. The Xrp1/Irbp18 heterodimer activates transcription by binding to a sequence motif identified from both in vitro studies and ChIP-Seq in vivo [3,5,52]. Like Xrp1, Irbp18 is also required for cell competition, suggesting that transcriptional targets of the Xrp1/Irbp18 heterodimer are involved [49].

Xrp1 induction in Rp+/- cells does not require p53 [8]. In Rp+/- cells, Xrp1 expression is instead induced by a particular Rp, RpS12, which is necessary for cell competition [8,53,54]. Mutations in other Rp genes, as well as diminished rRNA synthesis, behave as though they increase RpS12 function [5,53,55]. RpS12 activates Xrp1 expression through alternative splicing of the Xrp1 mRNA to produce an active short isoform [56,57]. Other cellular stresses can also activate Xrp1 expression, at least some independently of both p53 and RpS12, in some cases using other Xrp1 isoforms [5,6,11,33,58–62].

In Drosophila, cell competition is part of the response to aneuploidy [13,63–65]. Because the genes encoding 80 Rp are distributed around the chromosomes, loss of chromosome segments constituting more than 1.2% of the genome (on average) typically leads to haploinsufficiency for one Rp gene or another by removing one copy of that locus. This leads to the elimination of cells bearing many segmental monosomies by the same cell competition pathway that affects Rp+/- point mutant cells [13]. Accordingly, Drosophila lacking cell competition can accumulate cells with certain kinds of genetic damage, not because they experience any defect in DNA repair, but because some abnormal genotypes that would ordinarily be eliminated by cell competition survive when cell competition is inhibited. Adult flies with a mutation in RpS12 that prevents cell competition exhibit an increased frequency of sporadic cells exhibiting the typical Rp+/-mutant thin bristle phenotype, whether occurring spontaneously or after irradiation. Many of these cells likely harbor chromosome deletions that affect multiple genes in addition to one of the Rp loci [13]. Mutations in p53 do not increase the frequency of these putatively aneuploid cells, suggesting that even when DNA repair is impaired, cell competition is sufficient to recognize and eliminate them [13,64].

Because Xrp1 has been implicated in two processes that impact genome integrity, we sought here to define the respective roles more precisely. Loss of heterozygosity after irradiation of Xrp1 mutants could either arise through defects in p53-dependent DNA repair or apoptosis, or due to failure to outcompete cells bearing irradiation-induced segmental aneuploidies. We now report that Xrp1 is indeed important for the DDR, mediating the expression of most of the p53-target genes and contributing to p53-induced apoptosis and the repair or removal of DNA damage. If cells with unrepaired DNA and damaged genomes accumulate after DNA repair, many are subsequently removed by p53-independent, Xrp1-dependent cell competition. Thus, Xrp1 plays at least two roles in genome integrity.

These findings may provide insight into mammalian cancer development. P53 is one of the most important human tumor suppressors, mutated in more than 50% of human cancers [66]. Although p53 ensures genomic integrity as the key effector of the DDR [21,67], it has been questioned whether this is the basis for tumor suppression. Point mutations that block p53 function in the acute DDR have little effect in blocking tumor growth, and conditional knock-out studies point to a critical window for tumor suppressor function that is subsequent to the resolution of DNA damage [24,68–70]. In mammals, which seem to lack a clear Xrp1 ortholog, p53 is required for cell competition, potentially substituting functionally for the role of Xrp1 in Drosophila [23,25,71–73]. Cell competition could provide a second role for mammalian p53 in genome integrity, contributing to tumor suppression, if it were found to eliminate aneuploid cells, analogous to the way that Xrp1 contributes to both DDR and cell competition in Drosophila.

Results

DNA damage-induced expression of Xrp1

Studies on irradiated Drosophila embryos and larval tissues indicate that DNA Damage-induced apoptosis proceeds in two phases [13,64,74,75]. An initial acute, p53-dependent DDR peaks in the first 4 hours (Fig 1A). This is followed by a p53-independent phase of apoptosis after about 24h thought to include cell competition (Fig 1A). Xrp1 mRNA is upregulated by p53 within 30 minutes of irradiation of Drosophila embryos [1,2], perhaps by direct binding of p53 within the Xrp1 locus [76]. We explored Xrp1 mRNA and protein expression to confirm that Xrp1 is also a p53 target in third-instar larval wing discs. We used a fly line in which the Xrp1 protein was expressed from the endogenous locus, containing a C-terminal HA tag [49]. Wild-type wing discs exhibited only a few Xrp1-HA-positive cells, possibly reflecting spontaneous DNA damage or other cellular stress (Fig 1B). Exposure to ionizing radiation (IR: 1500 Rads of γ-rays) induced strongly Xrp1-HA positive cells by 2 hours after IR, which further increased by 4 hours after IR (Fig 1C-1D). The DNA damage-induced Xrp1-HA expression was non-uniform, with some cells showing higher expression levels than others. This heterogeneity was different from the more uniform Xrp1-HA expression seen in Rp+/- mutant wing discs (Fig 1E). A similar salt-and-pepper pattern of Xrp1 was observed with the Xrp1 antibody (Fig 1F, 1G). The specificity of Xrp1-HA expression was further confirmed by its reduction after RNAi for Xrp1 (Fig 1H).

thumbnail
Fig 1. DNA damage induced Xrp1 expression.

(A). Schematic of the approximate timeline of p53-dependent and p53-independent apoptotic responses following irradiation, based on previous work [2,13,64,74]. (B). Xrp1 protein levels in the wild type 3RD instar wing discs stained for HA, in 0 Rads (control) (C), 2 hours after 1500 Rads (D), 4 hours after 1500 Rads (E), and in Rp18+/- mutant (F). Larval wing discs stained with Xrp1 antibody, 0 Rads (control) (G), and 4 hours after 1500 Rads (H) (note: Xrp1 antibody shows higher background than Xrp1-HA). Xrp1-HA expression at 4 hours post-1500 Rads in the posterior compartment, compared relative to the anterior compartment, taken as an internal control, en-Gal4 driving UAS-Xrp1 RNAi (I), p53 dominant negative (UAS-p53H159N) (J), and UAS-Irbp18 RNAi (K). 3rd instar wing discs assayed for Xrp102515-lacZ enhancer trap expression detected by anti-βgal antibody in 0 Rads (L), 4 hours after 1500 Rads (M), and in the wing disc expressing UAS-p53H159N under control of en-Gal4, 4 hours after 1500 Rads (N). N = 7–8 discs were analyzed for every genotype, and each experiment was repeated at least 2–3 times. Genotypes: (B-D) Xrp1-HA, (E) p{hs:FLP}; FRT42 RpS18 p{ubi:GFP}, (F-G) w1118 (H) en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (VDRC 107860); Xrp1-HA, (I) en-Gal4::UAS-RFP, UAS-p53DNH159N (Bl. 8420); Xrp1-HA, (J) en-Gal4::UAS-RFP, UAS-Irbp18 RNAi; Xrp1-HA, (K-L) P (Meyer et al.) Xrp102515, (M) en-Gal4::UAS-RFP,UAS-p53DNH159N (Bl. 8420); P{PZ}Xrp102515.

https://doi.org/10.1371/journal.pgen.1012309.g001

We tested the requirement for p53 using a dominant-negative form encoded by the UAS-p53H159N transgene [77,78]. We drove expression in posterior wing compartments so that Xrp1-HA expression levels could be compared to the anterior compartments of the same wing discs as a control. Dominant-negative p53 significantly reduced IR-induced Xrp1-HA (Fig 1I). Xrp1 in wing imaginal disc was also p53-dependent at the transcript level, with a ~ 3x reduction in mRNA level seen after qRT-PCR from irradiated p53-/- wing discs (S1A Fig).

Interestingly, IR-induced Xrp1-HA protein expression was only slightly affected by Irbp18 knockdown (Fig 1J). This was different from Xrp1 expression in Rp+/- mutants, where Xrp1 autoregulation is important to regulate the level of Xrp1 expression [3,49]. Consistent with transcriptional autoregulation not contributing to IR-induced Xrp1 transcription, 50% of the normal Xrp1 mRNA level remained in the Xrp1m2-73/Df mutant background (S1A Fig). Thus, the Xrp1m2-73 point mutant allele could still be transcribed in response to irradiation, even without a functional Xrp1 product.

An Xrp1-LacZ enhancer trap has also been used as a reporter previously. It is upregulated in Rp+/- mutant wing discs [3,8]. Like Xrp1 protein and mRNA, Xrp1-LacZ was moderately elevated after irradiation (Fig 1K,1L). Different from Xrp1-HA, Xrp1-LacZ expression depended on Xrp1 and Irbp18 function, both after irradiation and in the unirradiated control (S1B-S1E Fig). Unexpectedly, reducing p53 function slightly elevated the expression of Xrp1-LacZ after irradiation (Fig 1M). We can’t completely explain these differences, although they suggest that Xrp1-LacZ might report auto-regulatory Xrp1 transcription but not p53-dependent transcription. We also observed differences between Xrp1-LacZ and endogenous Xrp1 expression in studies of a distinct cell competition mechanism [6].

Regulation of p53-dependent DDR target genes by Xrp1

In mammals, p53 regulates a complex transcriptional program of hundreds or even thousands of genes [21]. Depending on the study, however, only 122–346 p53-dependent genes have a p53 consensus motif in the promoter or upstream region [79,80]. It is thought that p53 directly controls core transcription programs that, in turn, regulate further secondary, indirect targets [81]. Xrp1 is a candidate for bringing secondary target genes under the indirect control of Drosophila p53. Consistent with this, when we compared 42 rapidly induced p53-target genes (RIPD) identified in the DDR [1,2], with Xrp1-dependent genes expressed in Rp+/- wing imaginal discs or discs overexpressing Xrp1 [3,8], we found 21 of 42 overlapped (Fig 2A). These genes were associated with Gene Ontology (GO) terms: transcription factors, cell death, DNA repair, and redox response (Fig 2B).

thumbnail
Fig 2. Xrp1 serves as the effector of p53 in DNA damage response.

Venn diagram showing the overlap of p53 [1,2] and Xrp1 [3,8] target genes (A). The table shows the genes organized according to GO categories from radiation-induced p53-dependent (RIPD) and genes common between Xrp1- and p53-dependent transcription programs (highlighted in bold) (B). Expression of TRE-dsRed in 3RD instar wing discs measured by staining for anti-βgal antibody, in the wild type (no IR) (C), 4 hours after 2000 Rads in wild type disc (D), UAS-p53H159N (E), UAS-Xrp1 RNAi (F), and UAS-Irbp18 RNAi (G). qRT-PCR analysis for mRNA expression levels from 3RD instar wing discs of w1118, p53[5A-1-4] and Xrp1m2-73/Df1 collected 3–4 hours after irradiation (1500 RADs) and normalized to untreated (0 Rads) sample, for the following genes egr (H), MMP1 (I), rad50 (J), mus205 (K), lig4 (L) and Ku80 (M). N = 7–8 discs were analyzed for every genotype, and each experiment was repeated at least 2–3 times. Data are presented as mean ± SEM, two-way ANOVA with Tukey’s multiple comparisons test was used. P < 0.05 was considered statistically significant. Genotype: ((C and D) TRE-dsRed, (E) TRE-dsRed::en-Gal4, UAS-p53H159N (Bl. 8420), (F) TRE-dsRed::en-Gal4, UAS-Xrp1 RNAi (VDRC 107860), (G) TRE-dsRed::en-Gal4, UAS-Irbp18 RNAi, (H-M) w1118, yw; p53[5A-1-4], and Xrp1m2-73/Df1.

https://doi.org/10.1371/journal.pgen.1012309.g002

We tested the contribution of Xrp1 to p53-dependent gene expression using reporter lines and qRT-PCR. The Jun N-terminal Kinase (JNK) pathway is activated in the DDR [82]. JNK activity is Xrp1-dependent in Rp+/- wing discs [8,53]. We found the JNK reporter TRE-dsRed was induced by IR in a p53-dependent manner (Fig 2C-2E), and this was Xrp1/Irbp18-dependent (Fig 2F & 2G). As expected, the JnK target gene MMP1 was also upregulated in a p53- and Xrp1-dependent manner (Fig 2I). The TNF-alpha ligand eiger (egr) has been proposed to activate JNK signaling in the DDR [83]. Surprisingly, however, egr transcription was p53-dependent but independent of Xrp1, which questions how much JNK signaling in the DDR depends on egr (Fig 2H).

All but one of the p53-dependent DNA repair genes induced in DDR were also potential Xrp1 targets (Fig 2B). We measured wing disc mRNA levels of representative genes from the major DNA repair pathways. These were the homologous recombination pathway gene rad50, the translesion polymerase DNA polymerase zeta subunit 1, mus205, and the Non-Homologous End Joining (NHEJ) pathway genes DNA ligase 4 (lig4) and Ku80. We found that IR-dependent expression of all these genes depended on Xrp1 at least as strongly as upon p53 (Fig 2J-2M).

A well-known aspect of DDR is the apoptotic death of severely damaged cells, dependent in Drosophila on p53-dependent induction of the pro-apoptotic genes rpr and hid [2,84]. To explore the role of Xrp1, we examined reporter lines for rpr and hid that are expressed in response to IR and widely used as p53 reporters [2,85,86]. The hid5’F-wt-EGFP reporter contains ~2 kb spanning the hid promoter from +16 to −2210 bp relative to the transcription start site [85,86] (Fig 3A). As expected, hid5’F-wt-EGFP was highly induced after IR in a p53-dependent manner (Fig 3B-3D). Both Xrp1 RNAi and Irbp18 RNAi reduced the hid5’F-wt-EGFP expression to the same extent as p53 dominant-negative did, suggesting that Xrp1 is the direct regulator of this reporter (Fig 3E-3F). Another reporter, hid20-10-lacZ, includes a distinct 10 kb sequence from the hid upstream region. hid20-10-lacZ was only slightly induced by IR, and no effect of Xrp1 and Irbp18 RNAi could be detected, although the small IR induction was p53-dependent (S2D-S2E and S2F-S2G Figs). Next, we assessed rpr expression using the rpr150-lacZ reporter, containing a 150 bp sequence including a putative p53 binding site ~4.8kb upstream of the rpr gene [87], and which has been used as a p53-reporter in wing discs [88]. In controls, rpr150-lacZ reporter exhibits uniform expression in most of the wing disc, on which is superimposed a region of elevated expression bordering the posterior wing pouch and notum region [89,90] (Fig 3L). It is now appreciated that many DDR genes have non-uniform expression patterns in the wing disc [91]. Because IR enhanced all aspects of rpr150-lacZ expression (Fig 3G,3H), we measured the average rpr150-lacZ expression level in anterior and posterior compartments and computed the ratio of posterior-to-anterior expression level as a readout of genetic perturbations applied to the posterior compartments. The increase in rpr150-lacZ following IR was p53-dependent, as expected, but unaffected by RNAi for either Xrp1 or Irbp18 (Fig 3G-3K and S2H-S2I Fig).

thumbnail
Fig 3. Xrp1 controls the expression of the regulatory sequences of the pro-apoptotic gene hid.

Schematic of H99 locus with approximate positions of rpr, hid, and grm and the reporter lines used for the analysis (A). Expression of hid5’F-wt-EGFP measured by staining for anti-GFP antibody, in the wild type (no IR) (B) and 4 hours after 2000 Rads in the wild type wing disc (C), UAS-p53H159N (D), UAS-Xrp1 RNAi (E), and UAS-Irbp18 RNAi (F). rpr150-lacZ expression measured by anti-βgal staining, in the wild type (no IR) (G) and 4 hours after 2000 Rads in the wild type wing disc (H). UAS-p53H159N (I), UAS-Xrp1 RNAi(J), and UAS-Irbp18 RNAi (K). qRT-PCR analysis for mRNA expression levels from 3RD instar wing discs of w1118, p53[5A-1-4], and Xrp1m2-73/Df1 collected 3–4 hours after irradiation (1500 RADs) and normalized to untreated (0 Rads) sample, for hid (L), and rpr (M). Putative DNA binding motif of Xrp1/Irbp18 heterodimer, adapted from Fly Factor Survey (N). Position of Xrp1/Irbp18 DNA motif in the upstream regulatory region of hid relative to the TSS (O). N = 5–8 discs were analyzed for every genotype. Data are presented as mean ± SEM, two-way ANOVA with Tukey’s multiple comparisons test was used. P < 0.05 was considered statistically significant. Genotype: (B & C) hid5’F-wt-EGFP, (D) hid5’F-wt-EGFP; en-Gal4::UAS-RFP, UAS-p53H159N (Bl. 8420), (E) hid5’F-wt-EGFP; en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (VDRC 107860), (F) hid5’F-wt-EGFP; en-Gal4::UAS-RFP, UAS-Irbp18 RNAi, (G & H) rpr150-lacZ, (I) rpr150-lacZ, UAS-p53H159N (Bl. 8420); hh-Gal4::UAS-GFP, (J) rpr150-lacZ, UAS-Xrp1 RNAi (VDRC 107860); hh-Gal4::UAS-GFP, (K) rpr150-lacZ, UAS-Irbp18 RNAi; hh-Gal4::UAS-GFP, (L-M) w1118, yw; p53[5A-1-4], and Xrp1m2-73/Df1.

https://doi.org/10.1371/journal.pgen.1012309.g003

To confirm that these studies of hid and rpr reporters were indeed reflective of the expression of the genes themselves, mRNA levels were measured in wing discs after IR. Consistent with the reporter studies, induction of hid mRNA by irradiation was completely dependent on p53 and partially dependent on Xrp1 (Fig 3L). Induction of rpr mRNA expression was completely dependent on p53 but was unaffected by the loss of Xrp1 (Fig 3M).

Taken together, these results show that genes identified as p53 targets in the Drosophila DDR include many that are potentially induced directly by Xrp1. Only two out of nine p53 target genes examined, egr and rpr, were induced independently of Xrp1. Analysis of p53 and Xrp1 binding motifs supported this conclusion. Sequences matching the p53-binding consensus have been identified in both the rpr150-lacZ reporter and the hid5’F-wt-EGFP reporter [87,92]. Consensus binding sites for the Xrp1/Irbp18 heterodimer [3,52] (Fig 3O) are footprinted by Xrp1/Irbp18 in the P-element terminal repeat and are sufficient to confer Xrp1/Irbp18-dependent transcription on luciferase reporters {[5] #4653; [50] #3670}. Using an in-silico motif finder (INSECT) [93], we found two Xrp1/Irbp18 binding motifs in the hid5’F-wt-EGFP reporter sequence and two in the hid20-10-lacZ reporter sequence (Fig 3P), but none in the rpr150-lacZ reporter that was expressed independently of Xrp1 and Irbp18 (Fig 3P). We conclude that, while rpr could be a direct target of p53 in the DDR, hid expression is partially dependent on Xrp1 induction downstream of p53, and the hid5’F-wt-EGFP reporter entirely so.

Xrp1 is sufficient for the expression of many p53-dependent DDR target genes

It was possible that the only Xrp1 requirement in the DDR might be to activate p53 to create a positive feedback loop. We used the rpr150-lacZ reporter, which is activated by p53 but not Xrp1, to test how p53 activity was affected by Xrp1 overexpression. Xrp1 overexpression in the wing pouch resulted in a huge amount of cell death, as expected (S3A-S3B Figs), but no discernible increase in rpr150-lacZ levels (S3C-S3D Figs). Similar results were obtained by expressing Xrp1 in the eye discs (Fig 4A-4B). Thus, Xrp1 did not cause p53 activation and is likely to act downstream of p53.

thumbnail
Fig 4. Xrp1 is sufficient for the expression of many p53- dependent DDR target genes.

rpr150-lacZ reporter expression measured by anti-βgal (red) and cell death by anti-Dcp-1 (green) in 3RD instar eye imaginal disc expressing UAS-RFP (A) and UAS-Xrp1 long isoform (B), under the control of GMR-Gal4 (blue). hid20-10-lacZ reporter expression measured by anti-βgal (red) and cell death by anti-Dcp-1 (green) in 3RD instar eye imaginal disc expressing UAS-RFP (C) and UAS-Xrp1 long isoform (D) under the control of GMR-Gal4 (blue). hid5’F-wt-EGFP reporter expression measured by anti-GFP (red) and cell death by anti-Dcp-1 (green) in 3RD instar eye imaginal disc expressing UAS-RFP (E) and UAS-Xrp1 long isoform (F) under the control of GMR-Gal4 (blue). N = 7–8 discs were analyzed for every genotype; each experiment was repeated at least 2 times. All the control and experimental genotypes shown in this figure were kept at 18°C to lessen the effect of Xrp1 overexpression. Genotype: (A-A’) GMR-Gal4::UAS-RFP, rpr150-lacZ, (B-B’) GMR-Gal4::UAS-RFP::UAS-Xrp1, rpr150-lacZ, (C-C’) GMR-Gal4::UAS-RFP; hid20-10-lacZ, (D-D’) GMR-Gal4::UAS-RFP::UAS-Xrp1; hid20-10-lacZ, (E-E’) hid5’F-wt-EGFP; GMR-Gal4::UAS-RFP, (F-F’) hid5’F-wt-EGFP; GMR-Gal4::UAS-RFP, UAS-Xrp1.

https://doi.org/10.1371/journal.pgen.1012309.g004

Next, we tested if Xrp1 was sufficient for the expression of target genes. Xrp1 overexpression in the eye disc led to a robust upregulation of hid20-10-lacZ (Fig 4C and 4D) and hid5’F-wt-EGFP (Fig 4E and 4F). Xrp1 also regulated JNK after DNA damage, and Xrp1 overexpression was sufficient to activate the JNK reporter TRE-dsRED (S3E-S3F Figs). These results show that Xrp1 functions downstream of p53 and is sufficient for expressing a subset of p53-dependent DDR genes.

Xrp1 contributes to DNA damage-induced cell death

To see whether the regulation of cell death genes by Xrp1 was functionally significant, the p53-dependent apoptosis that occurs in response to irradiation was examined. Cell death begins within 30 minutes after IR treatment and is entirely dependent on p53 for at least 4–5 hours [16,64]. Accordingly, p53 dominant-negative expression in posterior compartments substantially reduced the IR-induced cell death, leaving only a few cells positive for the cleaved Dcp-1 caspase (Fig 5A, 5B and 5D). Xrp1 RNAi (two independent lines) and Irbp18 RNAi both reduced cell death in the posterior compartment (Fig 5C-5D), although to a lesser extent than p53 dominant-negative did.

thumbnail
Fig 5. Xrp1 is partly required for DNA damage-induced cell death.

Drosophila 3RD instar wing imaginal discs dissected at 2 hours after 1500 Rads, cell death is measured by Dcp-1 (green and grayscale) in different genetic perturbations using en-Gal4 (posterior compartment (red)), UAS-RFP (A), UAS-p53H159N (B), and UAS-Xrp1 RNAi (C). Dcp-1 positive cells were quantified and plotted as the ratio of Dcp-1 positive cells in posterior (P) to anterior (A) compartments (D). Wing discs were dissected 4 hours after 1500 RADs and stained for Dcp-1 positive cells in FRT82 (E), FRT82p53[5A-1-4] (F), and FRT82Xrp1m2-73 (G). (H) Dcp-1 positive cells were quantified in the clone (RFP-/-), heterozygous tissue (RFP + /-) and in the sister clone (RFP + /+), 4-hour after IR. (E”-G”) display the magnified image of boxed area. Data are presented as mean ± SEM, two-tailed Welch’s t-test was used, and one-way ANOVA with Tukey’s multiple comparisons test was used. P < 0.05 was considered statistically significant. Genotype: (A) en-Gal4::UAS-RFP, (B) en-Gal4::UAS-RFP, UAS-p53DNH159N (Bl. 8420), (C) en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (Bl. 34521), (E) p{hs:FLP}; FRT82-RFP/FRT82 (30 min hs, 48 hr A.E.L), (F) p{hs:FLP}; FRT82-RFP/FRT82-p53[5A-1-4] (30 min hs, 48 hr A.E.L), (G) p{hs:FLP}; FRT82-RFP/FRT82-Xrp1m2-73 (30 min hs, 48 hr A.E.L).

https://doi.org/10.1371/journal.pgen.1012309.g005

We also examined the cell autonomy of p53 and Xrp1 function using clones of mutant cells. Control clones did not affect IR-induced cell death (Fig 5E and 5H). Cell death was reduced in p53+/- heterozygous cells and almost absent from p53-/- null clones after irradiation (Fig 5F and 5H). Cell death was also significantly reduced in Xrp1+/- (heterozygous) and even more so in Xrp1-/- (null) tissues as compared to Xrp1+/+ (wild type twin spot) (Fig 5G and 5H) (effects of Xrp1 mutation on Rp mutant cells are also dominant through haploinsufficiency) [8]. The Xrp1-/- mutant genotype reduced cell death to a greater extent than Xrp1 RNAi, although still not as much as p53-/- loss of function. Taken together, these results show that Xrp1 contributes to the p53-mediated cell death in response to irradiation (Fig 3R).

We also tested the contribution of Xrp1 to the effects of p53 overexpression. p53 overexpression in wing discs resulted in massive cell death that was partially but significantly reduced by Xrp1 knockdown or mutant genotypes (S4A-E and G Figs). In accordance with this partial dependence on Xrp1, p53 overexpression led to rather little Xrp1 protein expression (S4F Fig). Over-expression of p53 in the developing eye causes a rough eye phenotype in adults (S4H Fig) [77,78]. Xrp1 knockdown very slightly reduced the rough eye phenotype, unlike dominant-negative p53, which rescued it completely (S4I and S4J Figs).

RpS12-induced Xrp1 limits genomic instability after the DDR

The DDR is followed by a phase of p53-independent cell death, peaking around 24h after irradiation [75]. This has been attributed to the competitive loss of aneuploid cells mediated by altered Rp gene dose [64]. Consistently, irradiation leads to phenotypically Minute adult bristles, most of which are likely segmental monosomies [64]. Our previous studies supported this hypothesis [13]. We found that more Minute bristles accumulated when cell competition was blocked by mutating rpS12 [13]. We found that 66% of this delayed, p53-independent cell death that follows irradiation depended on rpS12; by contrast, rpS12 is not required for p53-dependent apoptosis in the DDR that peaks around 4h after IR, also confirmed here (S5A-S5C Figs) [13]. Consistent with the role of rpS12 being to initiate Xrp1-dependent cell competition of cells with a deficient dose of one or more Rp genes, Xrp1 was induced independently of p53 but most (58%) depended on rpS12 [13]. These findings were as expected if cell competition on the basis of altered Rp gene dose activates Xrp1 through RpS12, as would be expected of cells that acquire significant monosomies after DNA damage [13].

Here we have extended these studies, focusing on the functional contributions of Xrp1 and p53. As reported previously using an antibody against Xrp1 [13], we found that p53-independent cell death 24h post-IR was associated with Xrp1-HA expression. Just as found with Xrp1 antibody, more than half of the p53-independent Xrp1-HA expression depended on RpS12 (Fig 6E-6F & 6J). Xrp1-HA expression was also reduced in the rpS12G97D mutant when p53 was wild-type, although to a lesser degree, presumably because p53-dependent Xrp1 expression does not depend on RpS12 (Fig 6G-6H & 6I). We now find that 65% of p53-independent apoptosis 24h post-IR was Xrp1-dependent (Fig 6N- 6P), comparable to the 66% that was previously found to be RpS12- dependent [13]. Xrp1 also contributed to the total amount of apoptosis that occurred when p53 was not mutated (S5D-S5E Figs). These findings are consistent with the idea that delayed, p53-independent apoptosis 24h after irradiation includes competitive elimination of many cells containing aneuploidies that reduce Rp gene dose.

thumbnail
Fig 6. Xrp1 limits genomic instabilities by removing aneuploid cells in a p53-independent manner.

(A-H) Xrp1-HA expression in control disc no IR (A), Xrp1-HA expression in rpS12G97D/G97D mutant background no IR (B), Xrp1-HA expression 4 hours after 1500 rads in control disc (C), Xrp1-HA expression 4 hours after 1500 rads in rpS12G97D/G97D mutant background (D), Xrp1-HA expression 24 hours after 1500 rads in control disc (E), Xrp1-HA expression 24 hours after 1500 rads in rpS12G97D/G97D mutant background (F). Xrp1-HA expression 24 hours after 1500 rads in en > UAS-p53H159N (G). Xrp1-HA expression 24 hours after 1500 rads in en > UAS-p53H159N plus rpS12G97D/G97D mutant background (H). (I) Quantification of Xrp1-HA positive cells 4 and 24 hours after IR in control (C, E) and rpS12G97D/G97D mutant background (D, F). (J) Quantification of Xrp1-HA positive cells in posterior (Post.) compartments in UAS-p53H159N and UAS-p53H159N in rpS12G97D/G97D mutant background. (K-L) 3RD instar wing disc from larvae stained for cell death (Dcp-1, green), DNA damage signaling (γH2Av, red), control (en-Gal4, UAS-GFP) (K), and 4 hours after 1500 Rads of γ-rays treatment (L), (M-O) 3RD instar wing disc from larvae 24 hours after 1500 Rads of γ-rays treatment, stained for cell death (Dcp-1, green), DNA damage signaling (γH2Av, red) in control (en-Gal4, UAS-GFP) (M), p53-/- mutant (N), and Xrp1 k/d in p53-/- mutant background (O). (P-Q) Quantification of cDcp-1-positive (P) and γH2Av (Q) cells in anterior versus posterior compartments in p53-/- mutant and Xrp1 k/d in p53-/- mutant background. (R) γH2Av and (S) Xrp1-HA levels 24 hours after irradiation in the posterior compartment of the wing disc expressing p53H159N under the control of engrailed Gal4. hid5’F-wt-EGFP expression in UAS-p53H159N (T) and Xrp1 RNAi K/D (U) 24 hours after irradiation. N = 8 for (C & D), N = 10 for (E), N = 6 for (F), N = 8 for (G & H), and N = 15 for (N-O). (E). Data are plotted as mean ± SEM. One-way ANOVA with Tukey’s multiple comparisons test was used for (C-F), and a two-tailed Student’s t-test for independent samples for (G-H and N-O) was performed to assess statistical significance. Genotype: (A, C, E and G) Xrp1-HA, (B, D, F, H) Xrp1-HA-rpS12G97D/G97D, (I) en-Gal4::UAS-RFP; UAS-p53DNH159N (Bl. 8420); Xrp1-HA, (J) en-Gal4::UAS-RFP; UAS-p53DNH159N (Bl. 8420); Xrp1-HA-rpS12G97D/G97D, (K-L) en-Gal4::UAS-GFP, (M) en-Gal4::UAS-GFP; FRT82-RFP/FRT82-p53[5A-1-4], (N) en-Gal4::UAS-GFP; FRT82-RFP/FRT82-p53[5A-1-4], (O) en-Gal4::UAS-GFP, UAS-Xrp1 RNAi (VDRC 107860); FRT82-RFP/FRT82-p53[5A-1-4], (R) en-Gal4::UAS-RFP; UAS-p53DNH159N (Bl. 8420) (S) en-Gal4::UAS-RFP; UAS-p53DNH159N (Bl. 8420); Xrp1-HA, (T) hid5’F-wt-EGFP; en-Gal4::UAS-RFP, UAS-p53H159N (Bl. 8420), and (U) hid5’F-wt-EGFP; en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (VDRC 107860).

https://doi.org/10.1371/journal.pgen.1012309.g006

Unexpectedly, when p53 Inhibition was limited to posterior compartments so that anterior compartments of the same discs served as internal controls, it was clear that not only was much of the Xrp1 expression 24h post-IR independent of p53, but that it was actually increased by p53 inhibition (Fig 6G). Some of this increase was rpS12-dependent (Fig 6G-6H & 6J), consistent with more cell competition occurring after p53 inhibition. Since cell competition of Rp+/- cells is not affected by p53 in Drosophila [34], this is more likely explained by the presence of more Rp haploinsufficient cells when p53 had been inhibited during the DDR.

To investigate how p53 inhibition impacts genome integrity further, we looked at IR-induced DNA damage using antibodies against γH2Av, which marks the double-strand breaks [94,95]. Consistent with previous reports, the acute DNA damage revealed by γH2Av staining 4h after IR was mostly repaired by 24 hours post IR (Fig 6K-6M) [64,74]. This was not true in the absence of p53, however: γH2Av levels remained high, indicating persistent double-strand breaks (Fig M,N). Dual Xrp1 knockdown and p53 inhibition led to an even further increase (Fig 6O,6Q), and there was also a small but reproducible elevation of γH2Av levels when only Xrp1 was depleted (S5D and S5F Figs). These data indicated that p53 was required for the full repair of irradiation-damaged DNA (or for the removal of some cells with incomplete repair). Some cells where this damage persists were then removed or repaired by p53-independent Xrp1 activity, to which cell competition might contribute (Fig 6R-6S). Another indication of a role of Xrp1 independent of p53 came from hid5’F-wt-EGFP expression, which was totally dependent on Xrp1 24h after IR, but only partially dependent on p53 (Fig 6T-6U). Because Xrp1 function in the DDR is downstream of p53, this role of Xrp1 in p53 mutants may instead reflect the late, p53-independent function that also removes aneuploid cells. Importantly, aneuploid cells are not expected to label for γH2Av, because segmental aneuploidy arises when DNA breaks are joined inappropriately, not left unrepaired. Instead, persistent γH2Av labeling is a sign of delayed or defective repair processes that might also lead to more aneuploidy. Unfortunately, there is currently no straightforward assay that can identify all the aneuploid cells in imaginal discs; RpS12-dependent Xrp1 induction may be a useful surrogate marker for aneuploidy.

To get a better idea of when cell competition begins, wing discs were examined 16 hours post-IR. We found that most Xrp1-HA expression was independent of p53 by this stage (S5G-S5I Figs). Similar to 24 hours, Xrp1-HA was even higher in the absence of p53. However, similar to 4 hours after IR, Xrp1 knockdown suppressed Xrp1-HA expression at 16 hours post-IR, but Irpb18 did not (S5J, S5K Figs). Cell death occurring 16 hours after irradiation was substantially p53-dependent, although p53-independent cell death was also detected (S6L, S6M and S6O Figs). Cell death is almost completely p53-dependent at the acute DDR stage (Fig 5). Cell death 16 hours following irradiation was reduced by Xrp1 and Irbp18 depletion, but not eliminated (S5L, S5N and S5O Figs). These results suggest that p53-independent Xrp1 expression and function in cell competition are emerging by 16 hours and peaking by 24 hours after irradiation, perhaps indicating the timeline of the appearance of aneuploid cells.

Discussion

Xrp1 is known to contribute to genome integrity in Drosophila. Flies lacking Xrp1 exhibit increased loss-of-heterozygosity following irradiation, and also accumulate thin, Minute-like adult bristles indicative of monosomy for regions including Rp genes [1,13]. Here we affirm that Xrp1 contributes to genome maintenance at two levels (Fig 7). One is as a component of the acute DDR, mediating part of the p53 transcriptional response and p53-dependent apoptosis; the other role occurs later and appears to include cell competition to eliminate aneuploid and segmentally aneuploid cells that have acquired altered Rp gene dose as a result of DNA damage and its subsequent repair (Fig 7A). These two roles synergize to maintain somatic genome integrity after damage. They are distinguished in Drosophila by their mechanisms of induction. In the DDR, Xrp1 is induced transcriptionally by p53. RpS12 induces Xrp1 during cell competition. In mammals, by contrast, both the DDR and cell competition depend on p53 and are both potential contributors to p53-mediated tumor suppression.

thumbnail
Fig 7. Model.

(A) Our work reinforces the conclusion that an acute, p53-dependent apoptotic response to irradiation represents the DDR, while the later, p53-independent phase is associated with elimination of aneuploid cells by cell competition. The p53-independent phase depends more completely on Xrp1, whose expression at this stage is RpS12-dependent. The cell competition response is enhanced when p53 is absent, resulting in prolonged DNA damage and presumably an increase in aneuploidy. (B) The acute, p53-dependent DDR acts in part through Xrp1 as a downstream transcription factor. The DDR results in the repair of DNA damage or the removal of damaged cells by cell death. DNA repair can introduce errors (colored) including chromosome aberrations resulting in loss of genetic material (dashes). (C) When repair of DNA damage results in segmental aneuploidy, Xrp1 activation is triggered via an RpS12-dependent, p53-independent pathway that removes aneuploid cells via cell competition with unaffected cells.

https://doi.org/10.1371/journal.pgen.1012309.g007

Xrp1 is an effector of p53 in the DDR

In imaginal discs, Xrp1 is induced by p53 activity in the acute phase of DDR at both RNA and protein levels (Fig 1). Unlike Xrp1 induction in Rp+/- cells, Xrp1 expression in the DDR occurs independently of autoregulatory transcription, which may be why the Xrp1-LacZ enhancer trap shows less upregulation than the endogenous Xrp1 transcript and protein. Multiple p53-dependent DDR genes, in fact, the majority in our study, were Xrp1-dependent, including the pro-apoptotic gene hid. Even though the hid5’F-wt-EGFP reporter has been used as a readout of p53 activity [85,96–98], it may be more accurately described as a target of Xrp1. Other Xrp1 targets in the DDR include DNA repair genes and JNK signaling. These roles of Xrp1 were functionally required in the DDR. DNA damage-induced cell death was reduced in the absence of Xrp1, although not eliminated, perhaps because the pro-apoptotic gene rpr is a direct target of p53 that does not require Xrp1. Double strand break repair was also diminished when Xrp1 was depleted.

These findings confirmed that, in Drosophila, Xrp1 acted downstream to p53 as an intermediate transcription factor and controls many DDR targets. So far, integrating data from gene expression studies, binding motif and ChIP-Seq searches, and global run-on sequencing of nascent mRNA has not yielded a consensus on the core set of direct p53 target genes in mammals [79,99,100]. It is possible that, as in Drosophila, mammalian p53 acts as a master transcription factor that regulates a network of gene expression responses both directly and through intermediate transcription factors.

Xrp1 also controls genome integrity independently of p53 and the DDR

Although Xrp1 protein expression was almost completely p53-dependent during the acute DDR response, later Xrp1 expression was mostly p53-independent (S5 Fig). DNA damage is normally resolved by the time of p53-independent Xrp1 expression [74]. Without p53, however, DNA damage persisted longer than usual, so γH2Av labeling was still evident 24 h after irradiation (Fig 6). Persistent γH2Av staining may reflect ineffective DNA repair, insufficient apoptosis that permits badly damaged cells to survive, or both.

Previous work suggests that p53-independent cell death includes cell competition of cells whose genomes have been altered by irradiation. Because 80 Rp are encoded by genes spread throughout the genome, a loss of 1–2% of the genome will often create haploinsufficiency for one or more Rp genes and trigger elimination by cell competition [13]. Consistent with this mechanism, the delayed, p53-independent Xrp1 expression largely depended on RpS12, a signal of defective ribosome biogenesis that is required to induce Xrp1 in Rp+/- cells and cells with defective rRNA synthesis [5,8]. Accordingly, the p53-independent apoptosis occurring 24 hours after IR, and which is known to depend on RpS12, also depended on Xrp1 (Fig 6E, 6F, 6I). Xrp1 thus contributes to genome integrity at two levels, as a component of the p53-dependent DDR and later in a p53-independent manner, including RpS12-dependent cell competition that may remove cells where DDR has failed or has altered cell genotypes (Fig 7B,7C). RpS12-dependent cell death may depend on competition from neighboring cells because direct targets of p53, which include rpr, are not induced. In addition, since rpS12 is thought to affect targets besides Xrp1 [53,57], other rpS12 targets might increase the role of neighboring cells in cell competition.

Xrp1 expression levels were even further elevated during the cell competition phase if p53 had been inhibited (S6 Fig). Because this enhanced Xrp1 expression was p53-independent and at least partly RpS12-dependent, it was likely to include cell competition of aneuploid cells. This suggested that more aneuploid cells arose when p53 was not available to coordinate the DDR. γH2Av labeling also suggested that double-strand breaks persisted without p53. Importantly, γH2Av labeling is not itself a signature of aneuploid cells but reflects delayed and defective DNA repair processes that may correlate with increased aneuploidy. We think that without p53, DNA repair pathways, including DSB repair, single-strand break repair, and nucleotide excision repair, are delayed or less effective, and coupled with faulty cell cycle arrest, result in a higher frequency of genome rearrangements and aneuploidy [101].

Dual processes maintaining genome integrity following DNA damage

We have focused on two Xrp1-dependent processes contributing to genome integrity after DNA damage. The DDR depends on p53 in both Drosophila and mammals. Cell competition removes aneuploid cells in a p53-independent but rpS12-dependent manner in Drosophila, but is p53-dependent in mammals (Fig 7).

In mammals, the DDR was initially thought to reflect the tumor-suppressor function of p53. Later studies showed that tumor suppression is separable from the DDR and occurs afterward [24,68–70]. In mammals, where no clear Xrp1 homolog exists, Rp gene haploinsufficiency instead induces p53 through the nucleolar stress pathway [102]. Interestingly, differences in p53 activity levels between cells underlie multiple examples of cell competition in mammals [35,37–39]. Accordingly, we have suggested that in mammals, p53 takes on cell competition aspects of the Xrp1 function in Drosophila [71]. Consistent with this, p53 mediates the removal of aneuploid cells in mammals, which Xrp1 does in Drosophila [13,103]. If p53 eliminates aneuploid cells in mammals by Rp gene dose-dependent cell competition, as Xrp1 does in Drosophila, then dual roles for mammalian p53 could both contribute to tumor suppression, as dual roles for Xrp1 maintain genome integrity in Drosophila. Consistent with this, analyses of early cancer development in a mouse pancreatic cancer model indicate that losses of single chromosomes or parts of chromosomes are very early steps in the progression toward transformation [104]. Mammalian cells with such small-scale monosomies only seem to survive in the absence of p53 [105,106]. Although further studies will be required to confirm the suggestion, the observations are consistent with the possibility that, by contributing to genome integrity at the tissue level after the initial repair of DNA damage, cell competition could represent a significant tumor-suppressive process in mammals [63].

Materials and methods

  1. Fly husbandry: Flies were raised at 25°C on standard cornmeal and molasses medium, containing the following ingredients per 1L: 18g yeast; 22g molasses; 80g malt extract; 9g agar; 65g cornmeal; 2.3g methyl para-benzoic acid; 6.35ml propionic acid. Larvae were not distinguished for their sex before dissection.
  2. DNA damage γ-radiation treatment: Flies were grown in the standard cornmeal medium at 25°C. After egg laying was done for 24 hours, the flies were transferred to a fresh vial. Following this, the larvae were allowed to grow until the wandering late 3RD instar stage, and DNA damage was induced by treating them with γ-radiation from cesium-137 using a Shepherd irradiator. For most experiments, 1500 Rads were administered, and dissection was performed at a specified time point after the irradiation.
  3. Cell death quantification: Cell death was quantified by counting the number of Dcp-1 positive cells with the help of the ImageJ cell counter plugin. For UAS-Gal4 experiments, Dcp-1 positive cells in Gal4 to the control compartment were counted and compared as the ratio across different genetic perturbations. In the case of mutant wing discs, the number of Dcp-1 positive cells was counted in the entire disc, and the absolute number was compared.
  4. Immunohistochemistry: Imaginal discs were fixed using 4% formaldehyde in 1 × PBS, followed by 2 h blocking with 0.5% bovine serum albumin (BSA) dissolved in 0.1% PBST (1 × PBS with 0.1% Triton X-100). Primary antibody incubations were performed at 4°C overnight, followed by 2 hours of secondary incubation at room temperature. All washes following antibody incubation were performed in 0.1% PBST. Primary antibodies were against rabbit anti-cleaved Dcp-1 (Cell Signaling 9578, 1:200), mouse anti-γH2Av (DSHB UNC93-5.2.1, 1:50), mouse anti-βGalactosidase (DSHB 40a-1, 1:50), mouse anti-p53 (DSHB 25F4, 1:50), and mouse anti-GFP (DSHB 12A6, 1:50), mouse anti-HA (CST 2367, 1:100), and anti-Xrp1 (1:250; gift from Rio lab). Alexa Fluor (Thermo Fisher-Invitrogen) and Cyanine dye conjugated secondary antibodies (Jackson Immunoresearch) were used at a 1:200 dilution. Image acquisition was performed on the Leica-Sp8 microscope, intensity adjustments were made using Photoshop CC 2018, and Image J was used for image processing.

Previous experiments have supported that significant results could be obtained from 5 replicates; in most cases, more than 5 samples were analyzed. Experiments were repeated at least 2 times or more for most of the results. No exclusion of the data points was made while performing statistical significance. For the quantitative data, N values are indicated in the figure legends. Statistical significance was performed using a Student’s t-test for independent or dependent means, as shown in the figure legends. For specific data sets, two-tailed Welch’s t-test was used, and one-way ANOVA with Tukey’s multiple comparisons test was used, as mentioned in the figure legends. Exact p-values are indicated in the figures.

q-RT PCR

Total RNA was extracted from wing imaginal discs of late-third instar larvae treated with 2000 Rads of IR; untreated larvae were taken as a control for normalization. Wing discs were collected in TRIzol reagents (Ambion), and RNA was isolated according to the manufacturer’s instructions. RNA samples were DNase-treated according to the manufacturer’s instructions (Thermo Fisher; AM1907) and reverse transcribed using the Verso cDNA Synthesis Kit (Thermo Fisher; AB1453). The cDNA was used to perform the q-RT PCR reactions following the manufacturer’s instructions for the TaqMan Fast Advanced Master Mix (Thermo Fisher; 4444557). Custom design FAM-MGB TaqMan probes were utilized for q-RT-PCR. The gene expression values were normalized to the housekeeping gene RpL32. Similar results were obtained normalizing to actin. The following calculations were used for estimating fold change in gene expression ∆: Ct = Ct (gene of interest) – Ct (housekeeping gene), ∆∆Ct = ∆Ct (3–4 hr IR) – ∆Ct (untreated average), and Fold gene expression = 2^ -(∆∆Ct). 3 biological replicates were analysed for each condition and genotype. The gene expression analysis was performed using technical triplicates for each sample. It has been previously established that significant results can obtained 3 biological and 3 technical triplicates.

The following TaqMan probes were used in this study:

  1. p53 Dm02154335_g1
  2. Xrp1 Dm02142088_g1
  3. rpr Dm01823054_s1
  4. hid Dm01823031_m1
  5. GstD1 Dm02362792_s1
  6. eiger Dm01794373_m1
  7. rad50 Dm01817359_g1
  8. PolZ1 Dm01843262_g1
  9. DNAlig4 Dm01838632_g1
  10. 10. Ku80 Dm01791676_g1
  11. Drosophila RpL32 Dm02151827_g1
  12. Drosophila actin Dm02361909_s1

Supporting information

S1 Fig. Xrp1 RNA expression in response to DNA damage.

qRT-PCR analysis for Xrp1 mRNA expression levels from 3rd instar wing discs from the genotypes w1118, p53[5A-1-4], and Xrp1m2-73/Df1 collected 3–4 hours after irradiation (1500 RADs) and normalized to untreated (0 RADs) samples of the respective genotypes (A). 3RD instar wing discs assayed for Xrp102515-lacZ enhancer trap expression by anti-βgal antibody in 0 Rads for en > Xrp1 RNAi (B), en>Irbp18 RNAi (C), and 4 hours after 1500 Rads treatment in genotypes en > Xrp1 RNAi (D), en>Irbp18 RNAi (E). Number of wing discs analyzed for genotypes was N = 3 for B, N = 2 for C, N = 3 for D, and N = 5 for E. Data are presented as mean ± SEM, two-way ANOVA with Tukey’s multiple comparisons test was used. P < 0.05 was considered statistically significant. Genotype: (A) w1118, yw; p53[5A-1-4], and Xrp1m2-73/ Df1, (B & C) en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (VDRC 107860); P{PZ}Xrp102515, (C & E) en-Gal4::UAS-RFP, UAS-Irbp18 RNAi; P{PZ}Xrp102515

https://doi.org/10.1371/journal.pgen.1012309.s001

(TIF)

S2 Fig. hid20-10lacZ and rpr150lacZintensity quantification.

hid20-10-lacZ expression measured by anti-βgal staining in the wild type (no IR) (A) and 4 hours after 2000 Rads in wild type wing disc (B), UAS-p53H159N (C), UAS-Xrp1 (D), and UAS-Irbp18 RNAi (E). (F) Mean intensity quantification for hid20-10lacZ from the wing, the anterior compartment of the wing pouch, with and without IR for the genotypes shown in S2A-E Fig. (G) The mean posterior (P) to mean anterior (A) hid20-10lacZ, with and without IR for the genotypes shown in S2A-E Fig. (H) Mean intensity quantification for rpr150lacZ from the wing, the anterior compartment of the wing pouch, with and without IR for the genotypes shown in Fig 3G-3K. (I) The mean posterior (P) to mean anterior (A) rpr150lacZ expression ratio, with and without IR for the genotypes shown in Fig 3G-3K. Data are presented as mean ± SEM, one-way ANOVA with Tukey’s multiple comparisons test was used. P < 0.05 was considered statistically significant. Genotype: (A-E & F-G) yw; hid20-10-lacZ, en-Gal4::UAS-RFP, UAS-p53H159N (Bl. 8420); hid20-10-lacZ, en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (VDRC 107860); hid20-10-lacZ, en-Gal4::UAS-RFP, UAS-Irbp18 RNAi; hid20-10-lacZ. (H & I) rpr150-lacZ, rpr150-lacZ, UAS-p53H159N (Bl. 8420); hh-Gal4::UAS-GFP, rpr150-lacZ, UAS-Xrp1 RNAi (VDRC 107860); hh-Gal4::UAS-GFP, rpr150-lacZ, UAS-Irbp18 RNAi; hh-Gal4::UAS-GFP

https://doi.org/10.1371/journal.pgen.1012309.s002

(TIF)

S3 Fig. Xrp1 is sufficient for the expression of p53- dependent DDR target genes.

Xrp1-HA protein measured by anti-HA (red) and cell death by Dcp-1 (green) in the 3RD instar wing disc expressing UAS-RFP control (A) and UAS-Xrp1 long isoform (B) under the control of nub-Gal4 (blue). rpr150-lacZ reporter expression measured by anti-βgal (green) and cell death by anti-Dcp-1 (red) in 3RD instar wing imaginal disc expressing UAS-RFP (C) and UAS-Xrp1 (D) under the control of nub-Gal4. TRE-EGFP reporter expression measured by anti-GFP (green) and cell death by anti-Dcp-1 (red) in 3RD instar wing imaginal disc expressing UAS-RFP control (E) and UAS-Xrp1 (F) under the control of nub-Gal4 (blue). N = 7–8 discs were analyzed for every genotype, and each experiment was repeated at least 2 times. All the control and experimental genotypes shown in this figure were kept at 18°C to lessen the effect of Xrp1 overexpression. Genotype: (A) nub-Gal4::UAS-RFP, (B) nub-Gal4::UAS-RFP::UAS-Xrp1-HA, (C) nub-Gal4::UAS-RFP, rpr150-lacZ, (D) nub-Gal4::UAS-RFP::UAS-Xrp1-HA, rpr150-lacZ, (E) nub-Gal4::UAS-RFP, TRE-GFP, (F) nub-Gal4::UAS-RFP::UAS-Xrp1-HA, TRE-GFP.

https://doi.org/10.1371/journal.pgen.1012309.s003

(TIF)

S4 Fig. Xrp1 contributes to the p53 O/E phenotype.

(A) Control nub-Gal4 exhibits few Dcp-1 positive cells, and no p53 protein was detected by anti-p53 antibody. (B) nub-Gal4 driving p53 overexpression (GUS-p53) in the wing pouch exhibits elevated cell death measured by Dcp-1 and p53 protein. (C) Co-expressing UAS-Xrp1 RNAi and GUS-p53 under nub-Gal4 led to a decrease in cell death by approximately 50%. (D) Removing one copy by Xrp1m2-73/ + did not affect cell death. (E) Removing both copies of Xrp1 (Xrp1m2-73/Xrp1attp flox) results in a decrease in cell death of approximately 50%. Xrp1-HA expression was assayed by an anti-HA antibody in the wing disc, expressing p53 under the control of nub-Gal4 (F & F’). (G) Dcp1 intensity was quantified using ImageJ; N = 6 for each genotype. (H) Bright field photograph of Drosophila eye, rough eye phenotype due to constitutive expression of p53 under the control of GMR-promoter (GMR-p53). (I) Overexpression of dominant-negative p53 (UAS-p53H159N) rescues the rough eye phenotype. (J) Xrp1 knockdown by RNAi has a slight effect on the rough eye phenotype. Data are presented as mean ± SEM, one-way ANOVA with Tukey’s multiple comparisons test was used. P < 0.05 was considered statistically significant. All the control and experimental genotypes shown in this figure were kept at 18°C to lessen the effect of p53 overexpression. Genotype: (A) nub-Gal4; w1118, (B) nub-Gal4, GUS-p53, (C) nub-Gal4, GUS-p53; UAS-Xrp1 RNAi (Bl. 34521), (D) nub-Gal4, GUS-p53; Xrp1m2-73/ + , (E) nub-Gal4, GUS-p53; Xrp1m2-73/Xrp1attp flox, (F) nub-Gal4, GUS-p53; Xrp1-HA, (H) GMR-p53, (I) GUS-p53, GMR-Gal4; UAS-p53H159N (Bl. 4021), (J) GUS-p53, GMR-Gal4; UAS-Xrp1 RNAi (Bl. 4521)

https://doi.org/10.1371/journal.pgen.1012309.s004

(TIF)

S5 Fig. Transition to p53-independent DDR occurs around 16 hours post-irradiation.

(A-B) Cell death measured by anti-Dcp-1 (green and grayscale) in wing imaginal discs dissected at 2 hours after 1500 Rads, measured in en-Gal4 (posterior compartment (red)) versus anterior compartment UAS-RFP; rpS12G97D (A), and UAS-Xrp1 RNAi; rpS12G97D (B). Dcp-1 positive cells were quantified in anterior (A) and posterior (P) compartments and plotted as the P/A ratio (C). N = 6 discs for (A-C), data is plotted as mean ± SEM, and a student t-test, two-tailed for the independent sample, was performed for statistical significance. (D) Cell death measured by anti-Dcp-1 and damaged DNA measured by anti-γH2Av in wing imaginal discs dissected at 24 hours after 2000 Rads, measured in en-Gal4 (posterior compartment expressing Xrp1 RNAi versus anterior compartment control. The disc epithelium was projected from the apical surface to the bottom of the nuclear layer. More basal regions were not included because the vast amount of cell death that occurs in the 24h following irradiation is not all promptly cleared and accumulates in basal disc regions. (E) Quantitative comparison of P and A cell death counts, normalized to compartment area. Paired 2-tailed t-test indicated P = 0.02. (F) Quantitative comparison of P and A mean γH2Av level. Paired 2-tailed t-test indicated P = 0.0003. (G-K) Xrp1-HA expression in 3RD instar wing imaginal discs, no IR control disc (G), 16 hours after 1500 rads (H), UAS-p53H159N (I), UAS-Xrp1 RNAi (J), and UAS-Irbp1 RNAi (K). 3RD instar wing imaginal discs dissected at 16 hours after 1500 Rads, cell death is measured by Dcp-1 (green and grayscale) in different genetic perturbations using en-Gal4 (posterior compartment (red)), UAS-RFP (L), UAS-p53H159N (M), and UAS-Xrp1 RNAi (N). Dcp-1 positive cells were quantified and plotted as the ratio of Dcp-1 positive cells in posterior (P) to anterior (A) compartments (O). N = 4 for (D-F) student t-test was performed to test the significance between anterior and posterior compartment. N = 10 for (L-O), data are presented as mean ± SEM, one-way ANOVA with Tukey’s multiple comparisons test was used. P < 0.05 was considered statistically significant. Genotype: (A & B) Xrp1-HA, (C) en-Gal4::UAS-RFP; UAS-Xrp1 RNAi (VDRC 107860); Xrp1-HA, (D) en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (Bl. 34521), (G) en-Gal4::UAS-RFP; UAS-Irbp18 RNAi; Xrp1-HA, (H) en-Gal4::UAS-RFP; UAS-p53DNH159N (Bl. 8420); Xrp1-HA, (I) en-Gal4::UAS-RFP; UAS-p53DNH159N (Bl. 8420); Xrp1-HA-rpS12G97D/G97D (J) en-Gal4::UAS-RFP; rpS12G97D/G97D, (K) en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (VDRC 107860); rpS12G97D/G97D, (L) en-Gal4::UAS-RFP, UAS-p53DNH159N (Bl. 8420), (M) en-Gal4::UAS-RFP, UAS-Xrp1 RNAi (Bl. 34521), (N) en-Gal4::UAS-RFP, UAS-Irbp18 RNAi

https://doi.org/10.1371/journal.pgen.1012309.s005

(TIF)

Acknowledgments

We thank Drs. J. Secombe, M. Kiparaki, S. Nair, A. Kumar, and S. Muliyil for comments on an earlier version of the manuscript. Confocal microscopy was performed in the Analytical Imaging Facility of the Albert Einstein College of Medicine (supported by the NCI P30CA013330) using the Leica SP8 microscope acquired through NIH SIG 1S10 OD023591. The monoclonal antibody mAb40-1a developed by J. R. Sanes was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD and maintained at the University of Iowa, Department of Biology, Iowa City, IA 52242.

Disclaimer: Part of this research was supported by the Intramural Research Program of the National Institutes of Health (NIH). The contributions of the NIH authors were made as part of their official duties as NIH federal employees, are in compliance with agency policy requirements, and are considered Works of the United States Government. However, the findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the U.S. Department of Health and Human Services.

References

  1. 1. Akdemir F, Christich A, Sogame N, Chapo J, Abrams JM. p53 directs focused genomic responses in Drosophila. Oncogene. 2007;26(36):5184–93. pmid:17310982
  2. 2. Brodsky MH, Weinert BT, Tsang G, Rong YS, McGinnis NM, Golic KG, et al. Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage. Mol Cell Biol. 2004;24(3):1219–31. pmid:14729967
  3. 3. Baillon L, Germani F, Rockel C, Hilchenbach J, Basler K. Xrp1 is a transcription factor required for cell competition-driven elimination of loser cells. Sci Rep. 2018;8(1):17712. pmid:30531963
  4. 4. Hsu FT-Y, Smith-Bolton RK. Myc and Tor drive growth and cell competition in the regeneration blastema of Drosophila wing imaginal discs. Development. 2025;152(24):dev204760. pmid:41235509
  5. 5. Kiparaki M, Khan C, Folgado-Marco V, Chuen J, Moulos P, Baker NE. The transcription factor Xrp1 orchestrates both reduced translation and cell competition upon defective ribosome assembly or function. Elife. 2022;11:e71705. pmid:35179490
  6. 6. Kumar A, Baker NE. The CRL4 E3 ligase Mahjong/DCAF1 controls cell competition through the transcription factor Xrp1, independently of polarity genes. Development. 2022;149(22):dev200795. pmid:36278853
  7. 7. Langton PF, Baumgartner ME, Logeay R, Piddini E. Xrp1 and Irbp18 trigger a feed-forward loop of proteotoxic stress to induce the loser status. PLoS Genet. 2021;17(12):e1009946. pmid:34914692
  8. 8. Lee C-H, Kiparaki M, Blanco J, Folgado V, Ji Z, Kumar A, et al. A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell. 2018;46(4):456-469.e4. pmid:30078730
  9. 9. Lee C-H, Rimesso G, Reynolds DM, Cai J, Baker NE. Whole-Genome Sequencing and iPLEX MassARRAY Genotyping Map an EMS-Induced Mutation Affecting Cell Competition in Drosophila melanogaster. G3 (Bethesda). 2016;6(10):3207–17. pmid:27574103
  10. 10. Matsumoto R, Kanda H, Kawasaki A, Nakamura M, Nagata R, Xie H, et al. Genetic landscaping of cell competition uncovers two core pathways mediated by Xrp1 or Eiger/TNF in Drosophila. Genetics. 2026;233(1):iyag067. pmid:41807109
  11. 11. Ochi N, Nakamura M, Nagata R, Wakasa N, Nakano R, Igaki T. Cell competition is driven by Xrp1-mediated phosphorylation of eukaryotic initiation factor 2α. PLoS Genet. 2021;17(12):e1009958. pmid:34871307
  12. 12. Fusari E, Muzzopappa M, Gracia J, Milán M. Depletion of aneuploid cells is shaped by cell-to-cell interactions. Cell Genom. 2025;5(8):100894. pmid:40466636
  13. 13. Ji Z, Chuen J, Kiparaki M, Baker N. Cell competition removes segmental aneuploid cells from Drosophila imaginal disc-derived tissues based on ribosomal protein gene dose. Elife. 2021;10:e61172. pmid:33847264
  14. 14. Hopkins JL, Lan L, Zou L. DNA repair defects in cancer and therapeutic opportunities. Genes Dev. 2022;36(5–6):278–93. pmid:35318271
  15. 15. Németh E, Szüts D. The mutagenic consequences of defective DNA repair. DNA Repair (Amst). 2024;139:103694. pmid:38788323
  16. 16. Tiwari V, Wilson DM 3rd. DNA Damage and Associated DNA Repair Defects in Disease and Premature Aging. Am J Hum Genet. 2019;105(2):237–57. pmid:31374202
  17. 17. Vijg J. From DNA damage to mutations: All roads lead to aging. Ageing Res Rev. 2021;68:101316. pmid:33711511
  18. 18. Baker DJ, Jin F, Jeganathan KB, van Deursen JM. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell. 2009;16(6):475–86. pmid:19962666
  19. 19. Baker DJ, van Deursen JM. Chromosome missegregation causes colon cancer by APC loss of heterozygosity. Cell Cycle. 2010;9(9):1711–6. pmid:20404532
  20. 20. Hanks S, Coleman K, Reid S, Plaja A, Firth H, Fitzpatrick D, et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet. 2004;36(11):1159–61. pmid:15475955
  21. 21. Levine AJ, Hu W, Feng Z. The p53 pathway: what questions remain to be explored?. Cell Death Differ. 2006;13(6):1027–36.
  22. 22. Zhang X-P, Liu F, Wang W. Two-phase dynamics of p53 in the DNA damage response. Proc Natl Acad Sci U S A. 2011;108(22):8990–5. pmid:21576488
  23. 23. Boutelle AM, Attardi LD. p53 and Tumor Suppression: It Takes a Network. Trends Cell Biol. 2021;31(4):298–310. pmid:33518400
  24. 24. Kaiser AM, Attardi LD. Deconstructing networks of p53-mediated tumor suppression in vivo. Cell Death Differ. 2018;25(1):93–103. pmid:29099489
  25. 25. Baker NE. Emerging mechanisms of cell competition. Nat Rev Genet. 2020;21(11):683–97. pmid:32778819
  26. 26. Bergmann A. Cell death, compensatory proliferation, and cell competition. Annu Rev Genet. 2025.
  27. 27. Cong B, Cagan RL. Cell competition and cancer from Drosophila to mammals. Oncogenesis. 2024;13(1):1. pmid:38172609
  28. 28. Khandekar A, Ellis SJ. An expanded view of cell competition. Development. 2024;151(22):dev204212. pmid:39560103
  29. 29. Krishnan S, Paul PK, Rodriguez TA. Cell competition and the regulation of protein homeostasis. Curr Opin Cell Biol. 2024;87:102323. pmid:38301378
  30. 30. Lavalou J, Kulakova K, Subramaniam YJ, Piddini E. Mechanisms of cellular fitness and cell competition: Towards an integrated view. Curr Opin Cell Biol. 2025;96:102571. pmid:40784241
  31. 31. Morata G. Cell competition: A historical perspective. Dev Biol. 2021;476:33–40. pmid:33775694
  32. 32. Nagata R, Igaki T. Cell competition: emerging signaling and unsolved questions. FEBS Lett. 2024;598(4):379–89. pmid:38351618
  33. 33. Kiparaki M, Baker NE. Ribosomal protein mutations and cell competition: autonomous and nonautonomous effects on a stress response. Genetics. 2023;224(3):iyad080. pmid:37267156
  34. 34. Kale A, Li W, Lee C-H, Baker NE. Apoptotic mechanisms during competition of ribosomal protein mutant cells: roles of the initiator caspases Dronc and Dream/Strica. Cell Death Differ. 2015;22(8):1300–12. pmid:25613379
  35. 35. Bondar T, Medzhitov R. p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell. 2010;6(4):309–22. pmid:20362536
  36. 36. Dejosez M, Ura H, Brandt VL, Zwaka TP. Safeguards for cell cooperation in mouse embryogenesis shown by genome-wide cheater screen. Science. 2013;341(6153):1511–4. pmid:24030493
  37. 37. Fernandez-Antoran D, Piedrafita G, Murai K, Ong SH, Herms A, Frezza C, et al. Outcompeting p53-Mutant Cells in the Normal Esophagus by Redox Manipulation. Cell Stem Cell. 2019;25(3):329-341.e6. pmid:31327664
  38. 38. Marusyk A, Porter CC, Zaberezhnyy V, DeGregori J. Irradiation selects for p53-deficient hematopoietic progenitors. PLoS Biol. 2010;8(3):e1000324. pmid:20208998
  39. 39. Wagstaff L, Goschorska M, Kozyrska K, Duclos G, Kucinski I, Chessel A, et al. Mechanical cell competition kills cells via induction of lethal p53 levels. Nat Commun. 2016;7:11373. pmid:27109213
  40. 40. Zhang G, Xie Y, Zhou Y, Xiang C, Chen L, Zhang C, et al. p53 pathway is involved in cell competition during mouse embryogenesis. Proc Natl Acad Sci U S A. 2017;114(3):498–503. pmid:28049824
  41. 41. Morata G, Ripoll P. Minutes: mutants of drosophila autonomously affecting cell division rate. Dev Biol. 1975;42(2):211–21. pmid:1116643
  42. 42. Bridges CB, Morgan TH. The third-chromosome group of mutant characters of Drosophila melanogaster. Carnegie Institute Publication. 1923;327:1–251.
  43. 43. Marygold SJ, Roote J, Reuter G, Lambertsson A, Ashburner M, Millburn GH, et al. The ribosomal protein genes and Minute loci of Drosophila melanogaster [Comparative Study Research Support N.I.H. Extramural Research support, non-U.S. gov’t]. Genome Biol. 2007;8(10):R216.
  44. 44. Li W, Baker NE. Engulfment is required for cell competition. Cell. 2007;129(6):1215–25. pmid:17574031
  45. 45. Meyer SN, Amoyel M, Bergantinos C, de la Cova C, Schertel C, Basler K, et al. An ancient defense system eliminates unfit cells from developing tissues during cell competition [Research support, non-U.S. gov’t]. Science. 2014;346(6214):1258236.
  46. 46. Moreno E, Basler K, Morata G. Cells compete for decapentaplegic survival factor to prevent apoptosis in Drosophila wing development. Nature. 2002;416(6882):755–9. pmid:11961558
  47. 47. Simpson P. Parameters of cell competition in the compartments of the wing disc of Drosophila. Dev Biol. 1979;69(1):182–93. pmid:446891
  48. 48. Boulan L, Andersen D, Colombani J, Boone E, Léopold P. Inter-Organ Growth Coordination Is Mediated by the Xrp1-Dilp8 Axis in Drosophila. Dev Cell. 2019;49(5):811-818.e4. pmid:31006647
  49. 49. Blanco J, Cooper JC, Baker NE. Roles of C/EBP class bZip proteins in the growth and cell competition of Rp (’Minute’) mutants in Drosophila. Elife. 2020;9.
  50. 50. Francis MJ, Roche S, Cho MJ, Beall E, Min B, Panganiban RP, et al. Drosophila IRBP bZIP heterodimer binds P-element DNA and affects hybrid dysgenesis. Proc Natl Acad Sci U S A. 2016;113(46):13003–8. pmid:27799520
  51. 51. Reinke AW, Baek J, Ashenberg O, Keating AE. Networks of bZIP protein-protein interactions diversified over a billion years of evolution. Science. 2013;340(6133):730–4. pmid:23661758
  52. 52. Zhu LJ, Christensen RG, Kazemian M, Hull CJ, Enuameh MS, Basciotta MD, et al. FlyFactorSurvey: a database of Drosophila transcription factor binding specificities determined using the bacterial one-hybrid system. Nucleic Acids Res. 2011;39(Database issue):D111-7. pmid:21097781
  53. 53. Ji Z, Kiparaki M, Folgado V, Kumar A, Blanco J, Rimesso G, et al. Drosophila RpS12 controls translation, growth, and cell competition through Xrp1. PLoS Genet. 2019;15(12):e1008513.
  54. 54. Kale A, Ji Z, Kiparaki M, Blanco J, Rimesso G, Flibotte S, et al. Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell. 2018;44(1):42-55.e4. pmid:29316439
  55. 55. Baker NE, Kale A. Mutations in ribosomal proteins: Apoptosis, cell competition, and cancer. Mol Cell Oncol. 2015;3(1):e1029065. pmid:27308545
  56. 56. Kakemura B, Kanda H, Matsumoto R, Ueda S, Yasuhara S, Nagata R, et al. Cellular fitness is determined by ribosomal protein S12-mediated release of a truncated Xrp1. Cell Rep. 2026;45(4):117155. pmid:41894391
  57. 57. Tsakiri E, Potiri M, Kontogiannidi K, Douka K, Kanakousaki K, Vavouraki N, et al. RpS12-mediated induction of the Xrp1short isoform links ribosomal protein mutations to cell competition. Cell Rep. 2026;45(6):117380. pmid:42176268
  58. 58. Baumgartner ME, Dinan MP, Langton PF, Kucinski I, Piddini E. Proteotoxic stress is a driver of the loser status and cell competition. Nat Cell Biol. 2021;23(2):136–46. pmid:33495633
  59. 59. Brown B, Mitra S, Roach FD, Vasudevan D, Ryoo HD. The transcription factor Xrp1 is required for PERK-mediated antioxidant gene induction in Drosophila. eLife. 2021;10.
  60. 60. Katow H, Nguyen T, Park SH, Ryoo HD. The regulation of Xrp1 expression by uORFs and main ORF sequences and its function in Drosophila disease models. PLoS Genet. 2026;22(6):e1012203. pmid:42268918
  61. 61. Recasens-Alvarez C, Alexandre C, Kirkpatrick J, Nojima H, Huels DJ, Snijders AP, et al. Ribosomopathy-associated mutations cause proteotoxic stress that is alleviated by TOR inhibition. Nat Cell Biol. 2021;23(2):127–35. pmid:33495632
  62. 62. Shekhar S, Tracy C, Lidsky PV, Andino R, Wert KJ, Krämer H. Sensory quiescence induces a cell-non-autonomous integrated stress response curbed by condensate formation of the ATF4 and XRP1 effectors. Nat Commun. 2025;16(1):252. pmid:39747204
  63. 63. Baker NE, Montagna C. Reducing the aneuploid cell burden - cell competition and the ribosome connection. Dis Model Mech. 2022;15(11):dmm049673. pmid:36444717
  64. 64. McNamee LM, Brodsky MH. p53-independent apoptosis limits DNA damage-induced aneuploidy. Genetics. 2009;182(2):423–35. pmid:19364807
  65. 65. Titen SWA, Golic KG. Telomere loss provokes multiple pathways to apoptosis and produces genomic instability in Drosophila melanogaster. Genetics. 2008;180(4):1821–32. pmid:18845846
  66. 66. Muller PAJ, Vousden KH. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell. 2014;25(3):304–17. pmid:24651012
  67. 67. Kastenhuber ER, Lowe SW. Putting p53 in Context. Cell. 2017;170(6):1062–78. pmid:28886379
  68. 68. Christophorou MA, Martin-Zanca D, Soucek L, Lawlor ER, Brown-Swigart L, Verschuren EW, et al. Temporal dissection of p53 function in vitro and in vivo. Nat Genet. 2005;37(7):718–26. pmid:15924142
  69. 69. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature. 2006;443(7108):214–7. pmid:16957739
  70. 70. Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, et al. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 2012;149(6):1269–83. pmid:22682249
  71. 71. Baker NE, Kiparaki M, Khan C. A potential link between p53, cell competition and ribosomopathy in mammals and in Drosophila. Dev Biol. 2019;446(1):17–9. pmid:30513308
  72. 72. Lacroix M, Riscal R, Arena G, Linares LK, Le Cam L. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Mol Metab. 2020;33:2–22. pmid:31685430
  73. 73. Pilley S, Rodriguez TA, Vousden KH. Mutant p53 in cell-cell interactions. Genes Dev. 2021;35(7–8):433–48. pmid:33861719
  74. 74. Wells BS, Yoshida E, Johnston LA. Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity. Curr Biol. 2006;16(16):1606–15. pmid:16920621
  75. 75. Wichmann A, Jaklevic B, Su TT. Ionizing radiation induces caspase-dependent but Chk2- and p53-independent cell death in Drosophila melanogaster. Proc Natl Acad Sci U S A. 2006;103(26):9952–7. pmid:16785441
  76. 76. Kurtz P, Jones AE, Tiwari B, Link N, Wylie A, Tracy C, et al. Drosophila p53 directs nonapoptotic programs in postmitotic tissue. Mol Biol Cell. 2019;30(11):1339–51. pmid:30892991
  77. 77. Jin S, Martinek S, Joo WS, Wortman JR, Mirkovic N, Sali A, et al. Identification and characterization of a p53 homologue in Drosophila melanogaster. Proc Natl Acad Sci U S A. 2000;97(13):7301–6. pmid:10860994
  78. 78. Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S, et al. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53 [Research support, U.S. Gov’t, P.H.S.]. Cell. 2000;101(1):91–101.
  79. 79. Fischer M. Census and evaluation of p53 target genes. Oncogene. 2017;36(28):3943–56. pmid:28288132
  80. 80. Wei C-L, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell. 2006;124(1):207–19. pmid:16413492
  81. 81. Andrysik Z, Galbraith MD, Guarnieri AL, Zaccara S, Sullivan KD, Pandey A, et al. Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity. Genome Res. 2017;27(10):1645–57. pmid:28904012
  82. 82. Picco V, Pagès G. Linking JNK Activity to the DNA Damage Response. Genes Cancer. 2013;4(9–10):360–8. pmid:24349633
  83. 83. Sanchez JA, Mesquita D, Ingaramo MC, Ariel F, Milán M, Dekanty A. Eiger/TNFα-mediated Dilp8 and ROS production coordinate intra-organ growth in Drosophila. PLoS Genet. 2019;15(8):e1008133. pmid:31425511
  84. 84. Dekanty A, Barrio L, Milán M. Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of Drosophila epithelial cells. Oncogene. 2015;34(8):978–85. pmid:24632609
  85. 85. Fan Y, Lee TV, Xu D, Chen Z, Lamblin A-F, Steller H, et al. Dual roles of Drosophila p53 in cell death and cell differentiation. Cell Death Differ. 2010;17(6):912–21. pmid:19960025
  86. 86. Tanaka-Matakatsu M, Xu J, Cheng L, Du W. Regulation of apoptosis of rbf mutant cells during Drosophila development. Dev Biol. 2009;326(2):347–56. pmid:19100727
  87. 87. Brodsky MH, Nordstrom W, Tsang G, Kwan E, Rubin GM, Abrams JM. Drosophila p53 binds a damage response element at the reaper locus. Cell. 2000;101(1):103–13. pmid:10778860
  88. 88. Wells BS, Johnston LA. Maintenance of imaginal disc plasticity and regenerative potential in Drosophila by p53. Dev Biol. 2012;361(2):263–76. pmid:22036477
  89. 89. Alpar L, Bergantiños C, Johnston LA. Spatially Restricted Regulation of Spätzle/Toll Signaling during Cell Competition. Dev Cell. 2018;46(6):706-719.e5. pmid:30146479
  90. 90. Li Z, Wu C, Ding X, Li W, Xue L. Toll signaling promotes JNK-dependent apoptosis in Drosophila. Cell Div. 2020;15:7. pmid:32174999
  91. 91. Cruz J, Sun WY, Verbeke A, Hariharan IK. Single-cell transcriptomics of X-ray irradiated Drosophila wing discs reveals heterogeneity related to cell-cycle status and cell location. bioRxiv. 2025.
  92. 92. Wichmann A, Uyetake L, Su TT. E2F1 and E2F2 have opposite effects on radiation-induced p53-independent apoptosis in Drosophila. Dev Biol. 2010;346(1):80–9. pmid:20659447
  93. 93. Rohr CO, Parra RG, Yankilevich P, Perez-Castro C. INSECT: IN-silico SEarch for Co-occurring Transcription factors. Bioinformatics. 2013;29(22):2852–8. pmid:24008418
  94. 94. Khan C, Muliyil S, Ayyub C, Rao BJ. The initiator caspase Dronc plays a non-apoptotic role in promoting DNA damage signalling in D. melanogaster. J Cell Sci. 2017;130(18):2984–95. pmid:28751499
  95. 95. Lake CM, Holsclaw JK, Bellendir SP, Sekelsky J, Hawley RS. The development of a monoclonal antibody recognizing the Drosophila melanogaster phosphorylated histone H2A variant (γ-H2AV). G3 (Bethesda). 2013;3(9):1539–43. pmid:23833215
  96. 96. Chakravarti A, Thirimanne HN, Brown S, Calvi BR. Drosophila p53 isoforms have overlapping and distinct functions in germline genome integrity and oocyte quality control. Elife. 2022;11:e61389. pmid:35023826
  97. 97. Ruiz-Losada M, González R, Peropadre A, Gil-Gálvez A, Tena JJ, Baonza A, et al. Coordination between cell proliferation and apoptosis after DNA damage in Drosophila. Cell Death Differ. 2022;29(4):832–45. pmid:34824391
  98. 98. Zhang B, Mehrotra S, Ng WL, Calvi BR. Low levels of p53 protein and chromatin silencing of p53 target genes repress apoptosis in Drosophila endocycling cells. PLoS Genet. 2014;10(9):e1004581. pmid:25211335
  99. 99. Allen MA, Andrysik Z, Dengler VL, Mellert HS, Guarnieri A, Freeman JA, et al. Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. Elife. 2014;3:e02200. pmid:24867637
  100. 100. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008;9(5):402–12. pmid:18431400
  101. 101. Williams AB, Schumacher B. p53 in the DNA-Damage-Repair Process. Cold Spring Harb Perspect Med. 2016;6(5):a026070. pmid:27048304
  102. 102. Bursac S, Brdovcak MC, Donati G, Volarevic S. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis. Biochim Biophys Acta. 2014;1842(6):817–30. pmid:24514102
  103. 103. Singla S, Iwamoto-Stohl LK, Zhu M, Zernicka-Goetz M. Autophagy-mediated apoptosis eliminates aneuploid cells in a mouse model of chromosome mosaicism. Nat Commun. 2020;11(1):2958. pmid:32528010
  104. 104. Baslan T, Morris JP 4th, Zhao Z, Reyes J, Ho Y-J, Tsanov KM, et al. Ordered and deterministic cancer genome evolution after p53 loss. Nature. 2022;608(7924):795–802. pmid:35978189
  105. 105. Chunduri NK, Menges P, Zhang X, Wieland A, Gotsmann VL, Mardin BR, et al. Systems approaches identify the consequences of monosomy in somatic human cells. Nat Commun. 2021;12(1):5576. pmid:34552071
  106. 106. Hintzen DC, Soto M, Schubert M, Bakker B, Spierings DCJ, Szuhai K, et al. The impact of monosomies, trisomies and segmental aneuploidies on chromosomal stability. PLoS One. 2022;17(7):e0268579. https://doi.org/10.1371/journal.pone.0268579 pmid:35776704
  107. 107. Spradling AC, Stern D, Beaton A, Rhem EJ, Laverty T, Mozden N, et al. The Berkeley Drosophila Genome Project gene disruption project: Single P-element insertions mutating 25% of vital Drosophila genes. Genetics. 1999;153(1):135–77. pmid:10471706
  108. 108. Tsurui-Nishimura N, Nguyen TQ, Katsuyama T, Minami T, Furuhashi H, Oshima Y, et al. Ectopic antenna induction by overexpression of CG17836/Xrp1 encoding an AT-hook DNA binding motif protein in Drosophila. Biosci Biotechnol Biochem. 2013;77(2):339–44. pmid:23391928
  109. 109. Ni J-Q, Zhou R, Czech B, Liu L-P, Holderbaum L, Yang-Zhou D, et al. A genome-scale shRNA resource for transgenic RNAi in Drosophila. Nat Methods. 2011;8(5):405–7. pmid:21460824
  110. 110. Vincent JP, Girdham CH, O’Farrell PH. A cell-autonomous, ubiquitous marker for the analysis of Drosophila genetic mosaics. Dev Biol. 1994;164(1):328–31. pmid:8026635
  111. 111. Davis I, Girdham CH, O’Farrell PH. A nuclear GFP that marks nuclei in living Drosophila embryos; maternal supply overcomes a delay in the appearance of zygotic fluorescence. Dev Biol. 1995;170(2):726–9. pmid:7649398
  112. 112. Struhl G, Basler K. Organizing activity of wingless protein in Drosophila. Cell. 1993;72(4):527–40. pmid:8440019
  113. 113. Newsome TP, Asling B, Dickson BJ. Analysis of Drosophila photoreceptor axon guidance in eye-specific mosaics. Development. 2000;127(4):851–60. pmid:10648243
  114. 114. Freeman M. Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell. 1996;87(4):651–60. pmid:8929534
  115. 115. Xu T, Rubin GM. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development. 1993;117(4):1223–37. pmid:8404527